Cytosorbents (CTSO) Free Cash Flow (2010 - 2026)
Cytosorbents (CTSO) posted Free Cash Flow of -$1.2 million for Q1 2026, up 76.22% on a QoQ basis from -$4.9 million in Q4 2025, and up 66.18% year-over-year from -$705876.1 in Q1 2025.
Cytosorbents (CTSO) Free Cash Flow (2010 - 2026) Analysis & Trends
Cytosorbents' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- Quarterly Free Cash Flow rose 66.18% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.2 million (up 21.36% YoY) and the FY2025 annual result came in at -$12.5 million, up 13.13% from the prior year.
- Free Cash Flow was -$1.2 million for Q1 2026 at Cytosorbents, up from -$4.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $173636.0 in Q4 2022 and bottomed at -$12.4 million in Q3 2022.
- A 5-year average of -$4.6 million and a median of -$4.8 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow surged 101.9% — and 2023, when it plunged 4100.05%.
- Cytosorbents' Free Cash Flow stood at $173636.0 in 2022, then plunged by 4100.05% to -$6.9 million in 2023, then surged by 69.28% to -$2.1 million in 2024, then plunged by 131.16% to -$4.9 million in 2025, then jumped by 76.22% to -$1.2 million in 2026.
- Business Quant data shows CTSO's Free Cash Flow at -$1.2 million in Q1 2026, -$4.9 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Cytosorbents | 23.46 Mn | 18.66 Mn | 6.13 Mn | -1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 Mn |
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | -2.59 Mn |
| Sep 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -1.55 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Mar 31, 2024 | -4.87 Mn |
| Mar 31, 2024 | -4.87 Mn |
| Dec 31, 2023 | -6.95 Mn |
| Dec 31, 2023 | -6.95 Mn |